RETIFANLIMAB-DLWR | B761334 | INCYTE CORP
Regulatory Exclusivities
| Type | Expiry | Status | Source |
|---|---|---|---|
| 12-Year BPCIA | Mar. 22, 2035 | Active | Computed |
| 7-Year Orphan | Mar. 22, 1930 | Expired | Purple Book |
Purple Book Patents
No listed patents in Purple Book.
Estimated Patent LOE
Based on latest discovered patent 12214036(method of use) · relevance 72/100
Estimate based on AI-discovered patents. No patents are officially listed in the Purple Book for this product.
5 AI-discovered patents, sorted by relevance.
No patent or exclusivity listings for this strength.